Exact Therapeutics A.S. (56F)
Market Open
11 Aug, 06:06
XFRA XFRA Primary 
XOSL €
0. 03
0
0%
€
3.23M Market Cap
- P/E Ratio
- Div Yield
0 Volume
0 Eps
€ 0.03
Previous Close Want to track 56F and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Exact Therapeutics A.S. (56F) Statistics
Valuation metrics
Market Cap 3.23M
Enterprise value -2.03M
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) 54.83
Price/Book (mrq) 0.65
Enterprise Value/Revenue -374.19
Enterprise Value/EBITDA 0.27
Overview
Shares outstanding 63.26M
Float 16.23M
Shares short -
% Held by insiders 0.34%
% Held by institutions 0.13%
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0.02
52-Week high 0.2
Beta 0.08
50-Day moving average 0.1
200-Day moving average 0.11
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -661.42%
Operational effectiveness
Return on assets -0.48%
Return on equity -1.19%
Income Statement
Revenue (ttm) 5.42K
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) 5.42K
EBITDA -7.51M
Net income to common (ttm) -7.99M
Diluted EPS (ttm) -0.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 2.24M
Total cash per share (mrq) 0.39
Total debt (mrq) 39.94K
Total Debt/Equity (mrq) 1.42
Current ratio (mrq) 1.65%
Book value per share (mrq) 0.04
Cash Flow
Cash flow statement -6.15M
Levered free cash flow (LFCF) -5.11M
